PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-08-10

Date Title Company
10-Aug-2020 Clovis Oncology Announces First Patient Enrolled in the Phase 2 Portion of the LIO-1 Trial Evaluating the Combination of Lucitanib and Opdivo in Gynecologic Cancers Clovis Oncology, Inc
10-Aug-2020 Tiziana Life Sciences plc Announces Closing of $57.25 Million Offering Tiziana Life Sciences plc (
10-Aug-2020 Vifor Pharma Group reports continued growth in H1 2020 Vifor Pharma Group
10-Aug-2020 Independent Review Committee Recommends Nordic Nanovector to focus on one dosage arm for the Pivotal PARADIGME Phase 2b Trial in Patients with 3L R/R FL Nordic Nanovector ASA
10-Aug-2020 CSL Behring to become latest partner in BaseLaunch Phase II CSL Behring
10-Aug-2020 BioNTech to Report Second Quarter 2020 Financial Results and Operational Update on August 11, 2020 BioNTech SE
10-Aug-2020 Novartis announces publication of Phase III ASCLEPIOS trials data in NEJM demonstrating efficacy of the ofatumumab in patients with relapsing multiple sclerosis Novartis
10-Aug-2020 Novartis receives EC approval for new Xolair® indication to treat severe chronic rhinosinusitis with nasal polyps Novartis
10-Aug-2020 Independent Review Committee Recommends Nordic Nanovector to focus on one dosage arm for the Pivotal PARADIGME Phase 2b Trial in Patients with 3L R/R FL Nordic Nanovector
10-Aug-2020 RedHill Biopharma’s Phase 2/3 COVID-19 Study Approved in Mexico RedHill Biopharma
10-Aug-2020 New Report: Regenerative Medicine & Advanced Therapies Sector Thriving Despite COVID-19 Alliance for Regenerative Medicine
10-Aug-2020 New Report: Regenerative Medicine & Advanced Therapies Sector Thriving Despite COVID-19 The Alliance for Regenerative Medicine
10-Aug-2020 Medigene AG: Medigene provides Q2 update and 6M report 2020 Medigene AG
10-Aug-2020 Lentiviral Vector Market Size, Global Growth Analysis 2020, Latest Innovation by: System Biosciences, LLC,Spark Therapeutics, Inc., Novasep Holding SAS, Uniqure N.V., Kaneka Eurogentec S.A., Regenxbio Inc CDN Newswire
10-Aug-2020 AMRYT TO PRESENT AT VIRTUAL CANACCORD GENUITY 40TH ANNUAL GROWTH CONFERENCE Amryt
10-Aug-2020 Freeline update on IPO Syncona Limited
10-Aug-2020 Freeline Announces Pricing of Initial Public Offering Freeline Therapeutics Holdings plc
10-Aug-2020 Autolus Therapeutics Reports Second Quarter 2020 Financial Results and Operational Progress Autolus Therapeutics plc
10-Aug-2020 OpenText enters agreement to serve as the platform of choice for enterprise information management for the U.S. National Institutes of Health OpenText
10-Aug-2020 First-line immunotherapy combination, nivolumab plus ipilimumab, demonstrates significant improvement in overall survival vs. chemotherapy in unresectable malignant pleural mesothelioma patients in a phase 3 trial Bristol Myers Squibb Company